List of insiders holdings for ASCENTAGE PHARMA GROUP INTERNATIONAL:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Zhai Yifan Chief Medical Officer | 2026-05-22 16:44:39 | 1,134,742 38,028,775 | 39,163,517 | Form 4 |
| 2 | Yang Dajun Chairman and CEO | 2026-05-22 16:18:28 | 1,587,338 37,277,984 | 38,865,322 | Form 4 |
| 3 | Wang Shaomeng Director | 2026-03-23 19:13:53 | 1,238,962 8,860,911 | 10,099,873 | Form 3 |
| 4 | Knapp Thomas J SVP/General Counsel | 2026-03-23 19:12:11 | 440,320 0 | 440,320 | Form 3 |
| 5 | Lu Simon Dazhong Director | 2026-03-23 19:19:45 | 87,387 0 | 87,387 | Form 3/A |
| 6 | LIPPMAN MARC E Director | 2026-03-23 19:12:26 | 67,104 0 | 67,104 | Form 3/A |
| 7 | SIDRANSKY DAVID Director | 2026-03-23 19:14:28 | 58,341 0 | 58,341 | Form 3/A |
| 8 | Ye Changqing Director | 2026-03-23 19:22:12 | 56,664 0 | 56,664 | Form 3/A |
| 9 | Wei Ren Director | 2026-03-23 19:24:04 | 56,664 0 | 56,664 | Form 3 |
| 10 | Bozilenko Marina Director | 2026-03-23 19:03:13 | 45,930 0 | 45,930 | Form 3/A |
| 11 | Yu Debra Director | 2026-03-23 19:20:32 | 45,930 0 | 45,930 | Form 3/A |
| 12 | Misra Veet Chief Financial Officer | 2026-04-21 13:37:44 | 18,584 0 | 18,584 | Form 4 |
| 13 | Cao Jin Chief Accounting Officer | 2026-04-20 11:55:59 | 18,283 0 | 18,283 | Form 3/A |
| 14 | Miyara Faical Chief Business Officer | 2026-06-29 15:27:26 | 0 0 | 0 | Form 3 |